Biote Corp. BTMD Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $192.22M-2.5% | $197.19M+6.4% | $185.36M+12.4% | $164.96M+18.3% | ||
| $54.86M-5.6% | $58.13M+0.4% | $57.88M+6.1% | $54.58M+11.8% | ||
| $137.36M-1.2% | $139.06M+9.1% | $127.48M+15.5% | $110.38M+21.9% | ||
| 71.5%+0.9pp | 70.5%+1.7pp | 68.8%+1.9pp | 66.9%+1.9pp | ||
| $101.81M-5.2% | $107.45M+8.7% | $98.83M-42.2% | $171.1M+249% | ||
| $35.55M+12.5% | $31.61M+10.3% | $28.66M— | —— | ||
| 18.5%+2.5pp | 16%+0.6pp | 15.5%— | —— | ||
| -$10.96M+0.4% | -$11M-72.9% | -$6.36M-54.1% | -$4.13M-147% | ||
| —— | -$30.6M— | —— | $62.43M+3,870% | ||
| $37.58M— | —— | —— | $1.71M-94.8% | ||
| $5.99M— | —— | —— | $388K+35.7% | ||
| $27.05M+757% | $3.16M-4.8% | $3.32M+136% | -$9.24M— | ||
| 14.1%+12.5pp | 1.6%-0.2pp | 1.8%+7.4pp | -5.6%— | ||
| $0.75+582% | $0.11+238% | -$0.08— | —— | ||
| $39.22M+11.5% | $35.19M+11.2% | $31.65M+158% | -$54.15M— | ||
| 20.4%+2.6pp | 17.8%+0.8pp | 17.1%+49.9pp | -32.8%— | ||
| $35.55M+12.5% | $31.61M+10.3% | $28.66M+151% | -$56.35M-325% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Biote Corp.'s revenue?
- Biote Corp. (BTMD) generated $188.2M in revenue over the trailing twelve months, down 5.6% year over year.
- Is Biote Corp. profitable?
- Biote Corp. reported $15.6M in net income over the trailing twelve months, a 8.3% net margin.
- What are Biote Corp.'s profit margins?
- Gross margin is 70.1% and operating margin is 15.4%, with a 8.3% net margin.
- What is Biote Corp.'s earnings per share?
- Biote Corp.'s diluted EPS over the trailing twelve months is $0.44.
- Where does Biote Corp.'s income statement data come from?
- Every line is extracted from Biote Corp.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
